These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6185584)

  • 1. Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein.
    Schrier RD; Pizer LI; Moorhead JW
    J Immunol; 1983 Mar; 130(3):1413-8. PubMed ID: 6185584
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.
    Nash AA; Gell PG; Wildy P
    Immunology; 1981 May; 43(1):153-9. PubMed ID: 7251047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunization of mice with specific HSV-1 glycoproteins.
    Chan WL
    Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
    Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
    Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
    Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
    Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.
    Nash AA; Phelan J; Gell PG; Wildy P
    Immunology; 1981 Jun; 43(2):363-9. PubMed ID: 6265348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of alloreactivity to syngeneic tumor immunity.
    Greene MI; Perry LL
    Transplant Proc; 1980 Mar; 12(1):80-6. PubMed ID: 6154362
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection.
    Ghiasi H; Cai S; Nesburn AB; Wechsler SL
    Virology; 1996 Oct; 224(1):330-3. PubMed ID: 8862430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
    Leung KN; Nash AA; Sia DY; Wildy P
    Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a shared idiotype by two IgM anti-herpes simplex virus monoclonal antibodies that recognize different determinants.
    Kennedy RC; Adler-Storthz K; Henkel RD; Dreesman GR
    J Immunol; 1983 Apr; 130(4):1943-6. PubMed ID: 6187827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between human adenoviruses in delayed-type hypersensitivity.
    Bakay M; Szalay K; Beladi I; Balint E; Lengyel A; Adam E; Olah T
    APMIS; 2005 Mar; 113(3):197-202. PubMed ID: 15799763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.